Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Endosc. Mar 16, 2023; 15(3): 153-162
Published online Mar 16, 2023. doi: 10.4253/wjge.v15.i3.153
Figure 1
Figure 1 The patient inclusion process in this study. GVB: Gastric varices bleeding; EVHT: Endoscopic variceal histoacryl injection therapy; PPI: Proton pump inhibitor; APG: Aluminium phosphate gel.
Figure 2
Figure 2 The causes of rebleeding are related to glue discharge ulcers and venous bleeding. A: After 2 wk of endoscopic treatment, the gastric fundus shows a draining ulcer; B: Fundic vein bleeding after 3 wk of endoscopic treatment, there was gastric fundic drainage, formation of an ulcer, and bleeding; C: Varices that did not disappear completely were spurting bleeding after 14 d of endoscopic therapy.